Search research articles
Contact Us
Filters
Showing results (241-250 of 274) with videos related to
Page
of 28
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 17, 2018
Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease
Gaël Nicolas, Rocío Acuña-Hidalgo, Michael J Keogh, et al.
The European Journal of Neuroscience
|
April 1, 2022
A comparison of blood and brain-derived ageing and inflammation-related DNA methylation signatures and their association with microglial burdens
Anna J Stevenson, Daniel L McCartney, Danni A Gadd, et al.
Genome Biology
|
October 6, 2004
Bioconductor: open software development for computational biology and bioinformatics
Robert C Gentleman, Vincent J Carey, Douglas M Bates, et al.
Brain : a Journal of Neurology
|
November 28, 2017
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies
Martí Colom-Cadena, Jordi Pegueroles, Abigail G Herrmann, et al.
Science (New York, N.Y.)
|
January 5, 2008
Comment on "Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry"
Mike Buckley, Angela Walker, Simon Y W Ho, et al.
Acta Neuropathologica
|
February 6, 2024
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease
Martí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, et al.
Plos One
|
August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus
Daniah Trabzuni, Mina Ryten, Warren Emmett, et al.
Cell Reports. Medicine
|
August 31, 2023
Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8
Makis Tzioras, Michael J D Daniels, Caitlin Davies, et al.
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
Suvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Cell Reports
|
December 12, 2019
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease
Eleanor K Pickett, Abigail G Herrmann, Jamie McQueen, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 274) with videos related to
Sort By:
Page
of 28
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 17, 2018
Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease
Gaël Nicolas, Rocío Acuña-Hidalgo, Michael J Keogh, et al.
The European Journal of Neuroscience
|
April 1, 2022
A comparison of blood and brain-derived ageing and inflammation-related DNA methylation signatures and their association with microglial burdens
Anna J Stevenson, Daniel L McCartney, Danni A Gadd, et al.
Genome Biology
|
October 6, 2004
Bioconductor: open software development for computational biology and bioinformatics
Robert C Gentleman, Vincent J Carey, Douglas M Bates, et al.
Brain : a Journal of Neurology
|
November 28, 2017
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies
Martí Colom-Cadena, Jordi Pegueroles, Abigail G Herrmann, et al.
Science (New York, N.Y.)
|
January 5, 2008
Comment on "Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry"
Mike Buckley, Angela Walker, Simon Y W Ho, et al.
Acta Neuropathologica
|
February 6, 2024
Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease
Martí Colom-Cadena, Jamie Toombs, Elizabeth Simzer, et al.
Plos One
|
August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus
Daniah Trabzuni, Mina Ryten, Warren Emmett, et al.
Cell Reports. Medicine
|
August 31, 2023
Human astrocytes and microglia show augmented ingestion of synapses in Alzheimer's disease via MFG-E8
Makis Tzioras, Michael J D Daniels, Caitlin Davies, et al.
The Lancet. Neurology
|
September 22, 2024
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
Suvankar Pal, Jeremy Chataway, Robert Swingler, et al.
Cell Reports
|
December 12, 2019
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease
Eleanor K Pickett, Abigail G Herrmann, Jamie McQueen, et al.
Page
of 28